BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 33709561)

  • 1. Blast counts are lower in the aspirate as compared to trephine biopsy in acute myeloid leukemia and myelodysplastic syndrome expressing CD56.
    Drexler B; Tzankov A; Martinez M; Baerlocher S; Passweg JR; Dirnhofer S; Tsakiris DA; Dirks J
    Int J Lab Hematol; 2021 Oct; 43(5):1078-1084. PubMed ID: 33709561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalization of bone marrow aspirates for hemodilution in flow cytometric analyses.
    Loken MR; Chu SC; Fritschle W; Kalnoski M; Wells DA
    Cytometry B Clin Cytom; 2009 Jan; 76(1):27-36. PubMed ID: 18548614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of blast percentage assessed by bone marrow trephine biopsy and aspirate smear of myeloid malignancies.
    Yang CF; Gau JP; Hsiao LT; Hsu CY
    Pathology; 2021 Oct; 53(6):740-745. PubMed ID: 33745704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia and myelodysplastic and myeloproliferative syndromes.
    Mann KP; DeCastro CM; Liu J; Moore JO; Bigner SH; Traweek ST
    Am J Clin Pathol; 1997 Jun; 107(6):653-60. PubMed ID: 9169661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenging task of enumerating blasts in the bone marrow.
    Hodes A; Calvo KR; Dulau A; Maric I; Sun J; Braylan R
    Semin Hematol; 2019 Jan; 56(1):58-64. PubMed ID: 30573046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of immunohistochemical markers in bone marrow sections to evaluate for myelodysplastic syndromes and acute myeloid leukemias.
    Dunphy CH; O'Malley DP; Perkins SL; Chang CC
    Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):154-9. PubMed ID: 17525626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions and relevance of blast percentage and treatment strategy among younger and older patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
    DiNardo CD; Garcia-Manero G; Pierce S; Nazha A; Bueso-Ramos C; Jabbour E; Ravandi F; Cortes J; Kantarjian H
    Am J Hematol; 2016 Feb; 91(2):227-32. PubMed ID: 26799610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
    Nagai K; Kohno T; Chen YX; Tsushima H; Mori H; Nakamura H; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M; Bennett JM
    Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD34 immunohistochemistry in bone marrow biopsies for early response assessment in acute myeloid leukemia.
    Jain S; Mahapatra M; Pati HP
    Int J Lab Hematol; 2015 Dec; 37(6):746-51. PubMed ID: 26248894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study.
    Rogers HJ; Vardiman JW; Anastasi J; Raca G; Savage NM; Cherry AM; Arber D; Moore E; Morrissette JJ; Bagg A; Liu YC; Mathew S; Orazi A; Lin P; Wang SA; Bueso-Ramos CE; Foucar K; Hasserjian RP; Tiu RV; Karafa M; Hsi ED
    Haematologica; 2014 May; 99(5):821-9. PubMed ID: 24463215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysplastic erythroid precursors in the myelodysplastic syndromes and the acute myeloid leukemias: Is there biologic significance? (How should blasts be counted?).
    Bennett JM; Tuechler H; Aul C; Strupp C; Germing U
    Leuk Res; 2016 Aug; 47():63-9. PubMed ID: 27258735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
    Kang LC; Dunphy CH
    Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow cellularity in myeloid stem cell disorders: impact of age correction.
    Tuzuner N; Cox C; Rowe JM; Bennett JM
    Leuk Res; 1994 Aug; 18(8):559-64. PubMed ID: 8065157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count.
    Chan GC; Wang WC; Raimondi SC; Behm FG; Krance RA; Chen G; Freiberg A; Ingram L; Butler D; Head DR
    Leukemia; 1997 Feb; 11(2):206-11. PubMed ID: 9009082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression pattern of CD56 (N-CAM) in human bone marrow biopsies infiltrated by acute leukemia.
    Khanlari B; Buser A; Lugli A; Tichelli A; Dirnhofer S
    Leuk Lymphoma; 2003 Dec; 44(12):2055-9. PubMed ID: 14959847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic classification of the myelodysplastic syndromes (MDS): combined utilization of bone marrow aspirates and trephine biopsies.
    Bartl R; Frisch B; Baumgart R
    Leuk Res; 1992; 16(1):15-33. PubMed ID: 1732665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
    Marchesi RF; Velloso EDRP; Garanito MP; Leal AM; Siqueira SAC; Azevedo Neto RS; Rocha V; Zerbini MCN
    Ann Diagn Pathol; 2020 Apr; 45():151459. PubMed ID: 32000075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
    Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V
    Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.